广发中证香港创新药(QDII-ETF)(513120)资产配置 |
|
报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
2024/3/31 |
5,629,420,000 |
- |
5,848,250,000 |
5,758,430,000 |
98% |
2023/12/31 |
6,699,520,000 |
- |
6,935,290,000 |
6,780,710,000 |
99% |
2023/9/30 |
3,987,820,000 |
- |
4,128,890,000 |
4,066,160,000 |
98% |
2023/6/30 |
2,439,010,000 |
- |
2,513,740,000 |
2,484,390,000 |
98% |
2023/3/31 |
500,580,000 |
- |
521,044,000 |
512,401,000 |
98% |
2022/12/31 |
182,458,000 |
- |
185,035,000 |
184,877,000 |
99% |
2022/9/30 |
107,503,000 |
- |
109,157,000 |
109,052,000 |
99% |
2022/7/5 |
41,317,500 |
- |
341,472,000 |
300,239,000 |
14% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。